[HTML][HTML] Protein oxidation-Formation mechanisms, detection and relevance as biomarkers in human diseases
R Kehm, T Baldensperger, J Raupbach, A Höhn - Redox Biology, 2021 - Elsevier
Generation of reactive oxygen species and related oxidants is an inevitable consequence of
life. Proteins are major targets for oxidation reactions, because of their rapid reaction rates …
life. Proteins are major targets for oxidation reactions, because of their rapid reaction rates …
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng… - Gut, 2023 - gut.bmj.com
Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …
Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice
H Yang, T Yang, C Heng, Y Zhou, Z Jiang… - Phytotherapy …, 2019 - Wiley Online Library
Multiphase pathological processes involve in Type 2 diabetes (T2DM)‐induced
nonalcoholic fatty liver disease (NAFLD). However, the therapies are quite limited. In the …
nonalcoholic fatty liver disease (NAFLD). However, the therapies are quite limited. In the …
Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis
Background Non-alcoholic fatty liver disease (NAFLD) contributes to a large proportion of
liver disease burden in the world. Several groups have studied the prevalence of NAFLD in …
liver disease burden in the world. Several groups have studied the prevalence of NAFLD in …
[HTML][HTML] Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes
C Wang, Z Cai, X Deng, H Li, Z Zhao… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Background/aim: Previous studies have suggested that the hepatic steatosis index (HSI) and
fatty liver index (FLI) can be used as a predictor of non-alcoholic fatty liver disease (NAFLD) …
fatty liver index (FLI) can be used as a predictor of non-alcoholic fatty liver disease (NAFLD) …
Serum malondialdehyde is associated with non-alcoholic fatty liver and related liver damage differentially in men and women
S Zelber-Sagi, D Ivancovsky-Wajcman, N Fliss-Isakov… - Antioxidants, 2020 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) are
associated with increased oxidative stress and lipid peroxidation, but large studies are …
associated with increased oxidative stress and lipid peroxidation, but large studies are …
Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice
T Yang, H Yang, C Heng, H Wang, S Chen, Y Hu… - Food & function, 2020 - pubs.rsc.org
The intestinal microenvironment, a potential factor that contributes to the development of non-
alcoholic fatty liver disease (NALFD) and type 2 diabetes (T2DM), has a close relationship …
alcoholic fatty liver disease (NALFD) and type 2 diabetes (T2DM), has a close relationship …
Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced …
T Yang, Y Wang, X Cao, Y Peng, J Huang, L Chen… - Phytomedicine, 2023 - Elsevier
Background Hepatic lipid accumulation was a major promoter for the further development of
non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes (T2DM). mTOR/YY1 signaling …
non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes (T2DM). mTOR/YY1 signaling …
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based …
KS Kim, S Hong, K Han, CY Park - bmj, 2024 - bmj.com
Objective To investigate the risk of non-alcoholic fatty liver disease (NAFLD) for
cardiovascular disease and all cause death in patients with type 2 diabetes mellitus (T2DM) …
cardiovascular disease and all cause death in patients with type 2 diabetes mellitus (T2DM) …
Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
Background Non-alcoholic fatty liver disease (NAFLD) is a well-established risk factor for
cardiovascular disease, with ethnic and regional differences noted. With the recent surge of …
cardiovascular disease, with ethnic and regional differences noted. With the recent surge of …